Tuffin J R, Cunliffe D R, Shaw S R
Department of Oral Surgery, Plymouth General Hospital, Devon.
Br J Oral Maxillofac Surg. 1989 Feb;27(1):27-32. doi: 10.1016/0266-4356(89)90123-x.
A prospective, controlled, randomised, double-blind trial suggested that: 1. The use of bupivacaine 0.5% plain and prilocaine 3% with felypressin 0.03 i.u./ml. as peroperative local analgesics reduce postoperative pain scores recorded on the first postoperative morning (P less than 0.05). 2. Bupivacaine 0.5% plain reduces postoperative opiate requirements (P less than 0.025). 3. Patients do not find peroperative bilateral inferior alveolar and lingual nerve blocks with buccal infiltrations significantly unpleasant. Thus peri-operative bupivacaine 0.5% is a valuable adjunct to third molar removal under general anaesthesia.